NEW YORK, Aug. 8 (GenomeWeb News) - Less than four months ago, when Benitec exclusively licensed to Promega the rights to use its ddRNAi (DNA-directed RNAi) technology, the Australian company took a major step in its strategy to set up shop in the US as a therapeutics developer, executives from the companies indicated this week.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.